1
|
Ingrao F, Ngabirano E, Rauw F, Dauphin G, Lambrecht B. Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken. Vaccine 2024:S0264-410X(24)00452-3. [PMID: 38641498 DOI: 10.1016/j.vaccine.2024.04.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 03/15/2024] [Accepted: 04/11/2024] [Indexed: 04/21/2024]
Abstract
The application of recombinant herpesvirus of turkey, expressing the H9 hemagglutinin gene from low pathogenic avian influenza virus (LPAIV) H9N2 and the avian orthoavulavirus-1 (AOAV-1) (commonly known as Newcastle Disease virus (NDV)) fusion protein (F) as an rHVT-H9-F vaccine, is an alternative to currently used classical vaccines. This study investigated H9- and ND-specific humoral and mucosal responses, H9-specific cell-mediated immunity, and protection conferred by the rHVT-H9-F vaccine in specific pathogen-free (SPF) chickens. Vaccination elicited systemic NDV F- and AIV H9-specific antibody response but also local antibodies in eye wash fluid and oropharyngeal swabs. The ex vivo H9-specific stimulation of splenic and pulmonary T cells in the vaccinated group demonstrated the ability of vaccination to induce systemic and local cellular responses. The clinical protection against a challenge using a LPAIV H9N2 strain of the G1 lineage isolated in Morocco in 2016 was associated with a shorter duration of shedding along with reduced viral genome load in the upper respiratory tract and reduced cloacal shedding compared to unvaccinated controls.
Collapse
Affiliation(s)
- Fiona Ingrao
- Service of Avian Virology and Immunology, Sciensano, 1180 Brussels, Belgium.
| | - Eva Ngabirano
- Service of Avian Virology and Immunology, Sciensano, 1180 Brussels, Belgium
| | - Fabienne Rauw
- Service of Avian Virology and Immunology, Sciensano, 1180 Brussels, Belgium
| | - Gwenaëlle Dauphin
- Ceva Santé Animale, 10 Avenue de la Ballastière, 33500 Libourne, France
| | | |
Collapse
|
2
|
Valentin J, Ingrao F, Rauw F, Lambrecht B. Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules. Vaccine 2024; 42:1487-1497. [PMID: 38350766 DOI: 10.1016/j.vaccine.2023.11.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Revised: 11/06/2023] [Accepted: 11/28/2023] [Indexed: 02/15/2024]
Abstract
H5 highly pathogenic avian influenza (HPAI) viruses of the Asian lineage (A/goose/Guangdong/1/96) belonging to clade 2.3.4.4 have spread worldwide through wild bird migration in two major waves: in 2014/2015 (clade 2.3.4.4c), and since 2016 up to now (clade 2.3.4.4b). Due to the increasing risk of these H5 HPAI viruses to establish and persist in the wild bird population, implementing vaccination in certain sensitive areas could be a complementary measure to the disease control strategies already applied. In this study, the efficacy of a novel DNA vaccine, encoding a H5 gene (A/gyrfalcon/Washington/41088-6/2014 strain) of clade 2.3.4.4c was evaluated in specific pathogen-free (SPF) white leghorn chickens against a homologous and heterologous H5 HPAI viruses. A single vaccination at 2 weeks of age (1 dose), and a vaccination at 2 weeks of age, boosted at 4 weeks (2 doses), with or without adjuvant were characterized. The groups that received 1 dose with or without adjuvant as well as 2 doses with adjuvant demonstrated full clinical protection and a significant or complete reduction of viral shedding against homologous challenge at 6 and 25 weeks of age. The heterologous clade 2.3.4.4b challenge of 6-week-old chickens vaccinated with 2 doses with or without adjuvant showed similar results, indicating good cross-protection induced by the DNA vaccine. Long lasting humoral immunity was observed in vaccinated chickens up to 18 or 25 weeks of age, depending on the vaccination schedule. The analysis of viral transmission after homologous challenge showed that sentinels vaccinated with 2 doses with adjuvant were fully protected against mortality with no excretion detected. This study of H5 DNA vaccine efficacy confirmed the important role that this type of so-called third-generation vaccine could play in the fight against H5 HPAI viruses.
Collapse
Affiliation(s)
- Julie Valentin
- Sciensano, Service of Avian Virology and Immunology, 1180 Brussels, Belgium.
| | - Fiona Ingrao
- Sciensano, Service of Avian Virology and Immunology, 1180 Brussels, Belgium.
| | - Fabienne Rauw
- Sciensano, Service of Avian Virology and Immunology, 1180 Brussels, Belgium.
| | - Bénédicte Lambrecht
- Sciensano, Service of Avian Virology and Immunology, 1180 Brussels, Belgium.
| |
Collapse
|
3
|
Steensels M, Gelaude P, Van Borm S, Van Den Berg T, Cargnel M, Roupie V, Rauw F, Lambrecht B. Atypical Pathogenicity of Avian Influenza (H3N1) Virus Involved in Outbreak, Belgium, 2019. Emerg Infect Dis 2021; 26:1899-1903. [PMID: 32687049 PMCID: PMC7392414 DOI: 10.3201/eid2608.191338] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
In 2019, an outbreak of avian influenza (H3N1) virus infection occurred among commercial poultry in Belgium. Full-genome phylogenetic analysis indicated a wild bird origin rather than recent circulation among poultry. Although classified as a nonnotifiable avian influenza virus, it was associated with reproductive tropism and substantial mortality in the field.
Collapse
|
4
|
Steensels M, Van Borm S, Mertens I, Houdart P, Rauw F, Roupie V, Snoeck CJ, Bourg M, Losch S, Beerens N, van den Berg T, Lambrecht B. Molecular and virological characterization of the first poultry outbreaks of Genotype VII.2 velogenic avian orthoavulavirus type 1 (NDV) in North-West Europe, BeNeLux, 2018. Transbound Emerg Dis 2020; 68:2147-2160. [PMID: 33012090 PMCID: PMC8359175 DOI: 10.1111/tbed.13863] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 09/21/2020] [Accepted: 09/25/2020] [Indexed: 11/29/2022]
Abstract
After two decades free of Newcastle disease, Belgium encountered a velogenic avian orthoavulavirus type 1 epizootic in 2018. In Belgium, 20 cases were diagnosed, of which 15 occurred in hobby flocks, 2 in professional poultry flocks and 3 in poultry retailers. The disease also disseminated from Belgium towards the Grand Duchy of Luxembourg by trade. Independently, the virus was detected once in the Netherlands, almost simultaneously to the first Belgian detection. As such Newcastle disease emerged in the entire BeNeLux region. Both the polybasic sequence of the fusion gene cleavage site and the intracerebral pathotyping assay demonstrated the high pathogenicity of the strain. This paper represents the first notification of this specific VII.2 subgenotype in the North-West of Europe. Time-calibrated full genome phylogenetic analysis indicated the silent or unreported circulation of the virus prior to the emergence of three genetic clusters in the BeNeLux region without clear geographical or other epidemiological correlation. The Dutch strain appeared as an outgroup to the Belgian and Luxembourgian strains in the time-correlated genetic analysis and no epidemiological link could be identified between the Belgian and Dutch outbreaks. In contrast, both genetic and epidemiological outbreak investigation data linked the G.D. Luxembourg case to the Belgian outbreak. The genetic links between Belgian viruses from retailers and hobby flocks only partially correlated with epidemiological data. Two independent introductions into the professional poultry sector were identified, although their origin could not be determined. Animal experiments using 6-week- old specific pathogen-free chickens indicated a systemic infection and efficient transmission of the virus. The implementation of re-vaccination in the professional sector, affected hobby and retailers, as well as the restriction on assembly and increased biosecurity measures, possibly limited the epizootic and resulted in the disappearance of the virus. These findings emphasize the constant need for awareness and monitoring of notifiable viruses in the field.
Collapse
Affiliation(s)
- Mieke Steensels
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| | - Steven Van Borm
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| | - Ingeborg Mertens
- Federal Agency for the Safety of the Food Chain, General Direction Control Policy, The Belgian Federal Government, Brussels, Belgium
| | - Philippe Houdart
- Federal Agency for the Safety of the Food Chain, General Direction Control Policy, The Belgian Federal Government, Brussels, Belgium
| | - Fabienne Rauw
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| | - Virginie Roupie
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| | - Chantal J Snoeck
- Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
| | - Manon Bourg
- Laboratory of Veterinary Medicine, Veterinary Services Administration, Ministry of Agriculture, Viticulture and rural Development, Dudelange, Luxembourg
| | - Serge Losch
- Laboratory of Veterinary Medicine, Veterinary Services Administration, Ministry of Agriculture, Viticulture and rural Development, Dudelange, Luxembourg
| | - Nancy Beerens
- Division of Virology, AI/ND Reference Laboratory for the Netherlands, Wageningen Bioveterinary Research, Lelystad, The Netherlands
| | - Thierry van den Berg
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| | - Bénédicte Lambrecht
- Sciensano, Avian Virology and Immunology Service, AI/ND Reference Laboratory for Belgium and GD Luxembourg, Brussels, Belgium
| |
Collapse
|
5
|
Rauw F, Ngabirano E, Gardin Y, Palya V, Lambrecht B. Effectiveness of a Simultaneous rHVT-F(ND) and rHVT-H5(AI) Vaccination of Day-Old Chickens and the Influence of NDV- and AIV-Specific MDA on Immune Response and Conferred Protection. Vaccines (Basel) 2020; 8:vaccines8030536. [PMID: 32948028 PMCID: PMC7565404 DOI: 10.3390/vaccines8030536] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 09/10/2020] [Accepted: 09/11/2020] [Indexed: 11/16/2022] Open
Abstract
The recombinant herpesvirus of turkey (rHVT) vaccines targeting Newcastle disease (ND) and H5Nx avian influenza (AI) have been demonstrated efficient in chickens when used individually at day-old. Given the practical field constraints associated with administering two vaccines separately and in the absence of a currently available bivalent rHVT vector vaccine expressing both F(ND) and H5(AI) antigens, the aim of this study was to investigate whether interference occurs between the two vaccines when simultaneously administered in a single shot. The studies have been designed to determine (i) the ND and AI-specific protection and antibody response conferred by these vaccines inoculated alone or in combination at day-old, (ii) the influence of maternally-derived antibodies (MDA), and (iii) the potential interference between the two vaccine. Our results demonstrate that their combined administration is efficient to protect chickens against clinical signs of velogenic Newcastle disease virus (vNDV) and H5-highly pathogenic avian influenza virus (HPAIV) infections. Viral shedding following co-vaccination is also markedly reduced, while slightly lower NDV- and AIV-specific antibody responses are observed. NDV- and AIV-specific MDA show negative effects on the onset of the specific antibody responses. However, if AIV-specific MDA reduce the protection against H5-HPAIV induced by rHVT-H5(AI) vaccine, it was not observed for ND.
Collapse
Affiliation(s)
- Fabienne Rauw
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
- Correspondence:
| | - Eva Ngabirano
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
| | - Yannick Gardin
- CEVA Santé Animale, Avenue de la Ballastière 10, 33 500 Libourne, France;
| | - Vilmos Palya
- CEVA Phylaxia, Szállás utca 5, 1107 Budapest, Hungary;
| | - Bénédicte Lambrecht
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
| |
Collapse
|
6
|
Lagler J, Mitra T, Schmidt S, Pierron A, Vatzia E, Stadler M, Hammer SE, Mair KH, Grafl B, Wernsdorf P, Rauw F, Lambrecht B, Liebhart D, Gerner W. Cytokine production and phenotype of Histomonas meleagridis-specific T cells in the chicken. Vet Res 2019; 50:107. [PMID: 31806018 PMCID: PMC6896354 DOI: 10.1186/s13567-019-0726-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Accepted: 11/15/2019] [Indexed: 11/10/2022] Open
Abstract
The protozoan parasite Histomonas meleagridis is the causative agent of the re-emerging disease histomonosis of chickens and turkeys. Due to the parasite’s extracellular occurrence, a type-2 differentiation of H. meleagridis-specific T cells has been hypothesized. In contrast, a recent study suggested that IFN-γ mRNA+ cells are involved in protection against histomonosis. However, the phenotype and cytokine production profile of H. meleagridis-specific T cells still awaits elucidation. In this work, clonal cultures of a virulent monoxenic strain of H. meleagridis were used for infecting chickens to detect IFN-γ protein and IL-13 mRNA by intracellular cytokine staining and PrimeFlow™ RNA Assays, respectively, in CD4+ and CD8β+ T cells. Infection was confirmed by characteristic pathological changes in the cecum corresponding with H. meleagridis detection by immunohistochemistry and H. meleagridis-specific antibodies in serum. In splenocytes stimulated either with H. meleagridis antigen or PMA/ionomycin, IFN-γ-producing CD4+ T cells from infected chickens increased in comparison to cells from non-infected birds 2 weeks and 5 weeks post-infection. Additionally, an increase of IFN-γ-producing CD4−CD8β− cells upon H. meleagridis antigen and PMA/ionomycin stimulation was detected. Contrariwise, frequencies of IL-13 mRNA-expressing cells were low even after PMA/ionomycin stimulation and mainly had a CD4−CD8β− phenotype. No clear increase of IL-13+ cells related to H. meleagridis infection could be found. In summary, these data suggest that H. meleagridis infection induces a type-1 differentiation of CD4+ T cells but also of non-CD4+ cells. This phenotype could include γδ T cells, which will be addressed in future studies.
Collapse
Affiliation(s)
- Julia Lagler
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria.,Department for Farm Animals and Veterinary Public Health, Clinic for Poultry and Fish Medicine, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Taniya Mitra
- Department for Farm Animals and Veterinary Public Health, Clinic for Poultry and Fish Medicine, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Selma Schmidt
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Alix Pierron
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Eleni Vatzia
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Maria Stadler
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Sabine E Hammer
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Kerstin H Mair
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Beatrice Grafl
- Department for Farm Animals and Veterinary Public Health, Clinic for Poultry and Fish Medicine, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Patricia Wernsdorf
- Department for Farm Animals and Veterinary Public Health, Clinic for Poultry and Fish Medicine, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Fabienne Rauw
- Avian Virology & Immunology Unit, Sciensano, Brussels, Belgium
| | | | - Dieter Liebhart
- Department for Farm Animals and Veterinary Public Health, Clinic for Poultry and Fish Medicine, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Wilhelm Gerner
- Department of Pathobiology, Institute of Immunology, University of Veterinary Medicine Vienna, Vienna, Austria.
| |
Collapse
|
7
|
Nguyen GT, Rauw F, Steensels M, Ingrao F, Bonfante F, Davidson I, Lambrecht B. Study of the underlying mechanisms and consequences of pathogenicity differences between two in vitro selected G1-H9N2 clones originating from a single isolate. Vet Res 2019; 50:18. [PMID: 30823888 PMCID: PMC6397504 DOI: 10.1186/s13567-019-0635-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2018] [Accepted: 02/20/2019] [Indexed: 01/10/2023] Open
Abstract
The G1-H9N2 avian influenza virus (AIV) has caused significant economic losses in the commercial poultry industry due to reduced egg production and increased mortality. The field observations have shown that H9N2 viruses circulate and naturally mix with other pathogens and these simultaneous infections can exacerbate disease. To avoid an incorrect virus characterization, due to co-infection, isolates were purified by in vitro plaque assays. Two plaque purified G1-H9N2 clones, selected on different cell types, named MDCK-and CEF-clone in regards to the cell culture used, were studied in vivo, revealing two different virulence phenotypes. Subsequently, the underlying mechanisms were studied. Specifically, the phenotypical outcome of SPF bird infection by the two clones resulted in completely different clinical outcomes. These differences in clinical outcome were used to study the factors behind this output in more detail. Further studies demonstrated that the more severe disease outcome associated with the MDCK-clone involves a strong induction of pro-inflammatory cytokines and a lack of type I interferon production, whereas the mild disease outcome associated with the CEF-clone is related to a greater antiviral cytokine response. The immunosuppressive effect of the MDCK-clone on splenocytes was further demonstrated via ChIFN-γ lack production after ex vivo mitogenic stimulation. Genome sequencing of the two clones identified only four amino acid differences including three in the HA sequence (HA-E198A, HA-R234L, HA-E502D-H9 numbering) and one in the NA sequence (NA-V33M). In the present study, valuable insights on the mechanisms responsible for AI pathogenicity and molecular mechanisms of H9N2 infections in chicken were obtained while highlighting the impact of the cells viruses are grown on their virulence.
Collapse
Affiliation(s)
- Giang Thu Nguyen
- Avian Virology and Immunology Service, National Reference Laboratory for Avian Influenza and Newcastle Disease Virus, Sciensano, Uccle, Brussels, Belgium
| | - Fabienne Rauw
- Avian Virology and Immunology Service, National Reference Laboratory for Avian Influenza and Newcastle Disease Virus, Sciensano, Uccle, Brussels, Belgium
| | - Mieke Steensels
- Avian Virology and Immunology Service, National Reference Laboratory for Avian Influenza and Newcastle Disease Virus, Sciensano, Uccle, Brussels, Belgium
| | - Fiona Ingrao
- Avian Virology and Immunology Service, National Reference Laboratory for Avian Influenza and Newcastle Disease Virus, Sciensano, Uccle, Brussels, Belgium
| | | | - Irit Davidson
- Division of Avian and Diseases, Kimron Veterinary Institute, Bet Dagan, Israel
| | - Bénédicte Lambrecht
- Avian Virology and Immunology Service, National Reference Laboratory for Avian Influenza and Newcastle Disease Virus, Sciensano, Uccle, Brussels, Belgium.
| |
Collapse
|
8
|
Steensels M, Rauw F, van den Berg T, Marché S, Gardin Y, Palya V, Lambrecht B. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain. Avian Dis 2017; 60:202-9. [PMID: 27309056 DOI: 10.1637/11126-050615-reg.1] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
A highly pathogenic avian influenza (HPAI) H5N8 (clade 2.3.4.4) virus, circulating in Asia (South Korea, Japan, and southern China) since the beginning of 2014, reached the European continent in November 2014. Germany, the Netherlands, the United Kingdom, Italy, and Hungary confirmed H5N8 infection of poultry farms of different species and of several wild bird species. Unlike the Asian highly pathogenic (HP) H5N1, this HP H5N8 also went transatlantic and reached the American West Coast by the end of 2014, affecting wild birds as well as backyard and commercial poultry. This strain induces high mortality and morbidity in Galliformes, whereas wild birds seem only moderately affected. A recombinant turkey herpesvirus (rHVT) vector vaccine expressing the H5 gene of a clade 2.2 H5N1 strain (rHVT-H5) previously demonstrated a highly efficient clinical protection and reduced viral excretion against challenge with Asian HP H5N1 strains of various clades (2.2, 2.2.1, 2.2.1.1, 2.1.3, 2.1.3.2, and 2.3.2.1) and was made commercially available in various countries where the disease is endemic. To evaluate the protective efficacy of the rHVT-H5 vaccine against the first German H5N8 turkey isolate (H5N8 GE), a challenge experiment was set up in specific-pathogen-free (SPF) chickens, and the clinical and excretional protection was evaluated. SPF chickens were vaccinated subcutaneously at 1 day old and challenged oculonasally at 4 wk of age with two viral dosages, 10(5) and 10(6) 50% egg infective doses. Morbidity and mortality were monitored daily in unvaccinated and vaccinated groups, whereas viral shedding by oropharyngeal and cloacal routes was evaluated at 2, 5, 9, and 14 days postinoculation (dpi). Serologic monitoring after vaccination and challenge was also carried out. Despite its high antigenic divergence of the challenge H5N8 strain, a single rHVT-H5 vaccine administration at 1 day old resulted in a full clinical protection against challenge and a significant reduction of viral shedding in the vaccinated birds.
Collapse
Affiliation(s)
- M Steensels
- A Avian Virology & Immunology Service, Veterinary and Agrochemical Research Centre (CODA-CERVA), Groeselenberg, 99 B-1180 Brussels, Belgium
| | - F Rauw
- A Avian Virology & Immunology Service, Veterinary and Agrochemical Research Centre (CODA-CERVA), Groeselenberg, 99 B-1180 Brussels, Belgium
| | - Th van den Berg
- A Avian Virology & Immunology Service, Veterinary and Agrochemical Research Centre (CODA-CERVA), Groeselenberg, 99 B-1180 Brussels, Belgium
| | - S Marché
- A Avian Virology & Immunology Service, Veterinary and Agrochemical Research Centre (CODA-CERVA), Groeselenberg, 99 B-1180 Brussels, Belgium
| | - Y Gardin
- B Ceva Animal Health, Libourne, France
| | - V Palya
- C Ceva Animal Health, Budapest, Hungary
| | - B Lambrecht
- A Avian Virology & Immunology Service, Veterinary and Agrochemical Research Centre (CODA-CERVA), Groeselenberg, 99 B-1180 Brussels, Belgium
| |
Collapse
|
9
|
Gardin Y, Palya V, Dorsey KM, El-Attrache J, Bonfante F, Wit SD, Kapczynski D, Kilany WH, Rauw F, Steensels M, Soejoedono RD. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges. Avian Dis 2017; 60:232-7. [PMID: 27309060 DOI: 10.1637/11144-050815-resnote] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Vaccination against H5N1 highly pathogenic avian influenza (AI) virus (HPAIV) is one of the possible complementary means available for affected countries to control AI when the disease has become, or with a high risk of becoming, endemic. Efficacy of the vaccination against AI relies essentially, but not exclusively, on the capacity of the vaccine to induce immunity against the targeted virus (which is prone to undergo antigenic variations), as well as its capacity to overcome interference with maternal immunity transmitted by immunized breeding hens to their progeny. This property of the vaccine is a prerequisite for its administration at the hatchery, which assures higher and more reliable vaccine coverage of the populations than vaccination at the farm. A recombinant vector vaccine (Vectormune® AI), based on turkey herpesvirus expressing the hemagglutinin gene of an H5N1 HPAIV as an insert, has been used in several experiments conducted in different research laboratories, as well as in controlled field trials. The results have demonstrated a high degree of homologous and cross protection against different genetic clades of the H5N1 HPAIV. Furthermore, vaccine-induced immunity was not impaired by the presence of passive immunity, but on the contrary, cumulated with it for improved early protection. The demonstrated levels of protection against the different challenge viruses exhibited variations in terms of postchallenge mortality, as well as challenge virus shedding. The data presented here highlight the advantages of this vaccine as a useful and reliable tool to complement biosecurity and sanitary policies for better controlling the disease due to HPAIV of H5 subtypes, when the vaccination is applied as a control measure.
Collapse
Affiliation(s)
| | | | | | | | - Francesco Bonfante
- D Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Padova, Italy
| | - Sjaak de Wit
- E Gezondheidsdienst voor Dieren Animal Health, 7400 AA Deventer, the Netherlands
| | - Darrell Kapczynski
- F Southeast Poultry Research Laboratory, United States Department of Agriculture, Athens, GA 30605
| | - Walid Hamdy Kilany
- G National Reference Laboratory for Veterinary Quality Control on Poultry Production RLQP, Animal Health Research Institute, Agriculture Research Center, Ministry of Agriculture, P.O. 12618 - Box 264, Dokki, Giza, Egypt
| | - Fabienne Rauw
- H Avian Virology and Immunology Unit, Veterinary and Agrochemical Research Centre, 1180 Ukkel, Brussels, Belgium
| | - Mieke Steensels
- H Avian Virology and Immunology Unit, Veterinary and Agrochemical Research Centre, 1180 Ukkel, Brussels, Belgium
| | - Retno D Soejoedono
- I Faculty of Veterinary Medicine, Bogor Agricultural University, 16680 Bogor, Indonesia
| |
Collapse
|
10
|
Rauw F, Nguyen TG, Ngabirano E, Marché S, Lambrecht B. Specific antibody-mediated immunity in the reproductive tract of laying chickens immunized against Newcastle disease with conventional attenuated and inactivated vaccines. Avian Pathol 2017; 46:434-441. [PMID: 28290220 DOI: 10.1080/03079457.2017.1304528] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Despite the widespread and successful use of Newcastle disease (ND) vaccines, Newcastle disease virus (NDV) can seriously injure the reproductive tract of egg-laying hens, leading to rapid egg-drop and poor shell quality. Few published studies investigated local NDV-specific immune response in the reproductive tract after ND vaccination of hens. The present study investigated, for the first time, local NDV-specific antibody-mediated immunity in segments of the oviduct during the laying period. Specific pathogen-free (SPF) White Leghorn chickens were immunized following an ND vaccination programme applied in the field, which combined ND-attenuated vaccine (inoculated subcutaneously at one day, 2 weeks and 11 weeks of age) with inactivated vaccine (inoculated intramuscularly at 17 weeks). The infundibulum, magnum, isthmus and uterus (segments of the reproductive tract) were harvested at 28 weeks and 32 weeks of age (during the laying period). Supernatant from ex vivo tissue culture was collected and tested by: (i) haemagglutination inhibition (HI) test, (ii) commercial IDVet ND-enzyme-linked immunosorbent assay (ELISA) and (iii) NDV-specific IgG, IgM and IgA in-house ELISAs. For all sampling time points and oviduct segments, all samples were positive for commercial ND-ELISA and in-house ELISA-IgG. However, six of these ELISA-IgG positive samples yielded negative results when submitted to the HI test. Interestingly, NDV-specific IgM and IgA were detected frequently in the infundibulum and magnum as compared to the isthmus and uterus. These results show that the antibody immune response in the oviduct was induced by the timing of attenuated and inactivated ND vaccinations.
Collapse
Affiliation(s)
- F Rauw
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - T G Nguyen
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - E Ngabirano
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - S Marché
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - B Lambrecht
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| |
Collapse
|
11
|
Ingrao F, Rauw F, van den Berg T, Lambrecht B. Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens. Avian Pathol 2017; 46:289-299. [PMID: 27897452 DOI: 10.1080/03079457.2016.1265083] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Infectious bursal disease (IBD) is an avian viral disease that causes severe economic losses in the poultry industry worldwide. The live IBD virus (IBDV) has a potential immunosuppressive effect. Currently available IBDV vaccines have shortcomings, prompting the development of safer and more effective vaccination approaches, including the use of the recombinant turkey herpesvirus vaccine expressing the immunogenic structural VP2 protein of IBDV (recombinant HVT (rHVT)-IBD). The objectives of this study were twofold: (i) to develop in vitro assays and molecular tools to detect the VP2 protein and gene and (ii) to evaluate cell-mediated immunity (CMI) induced by rHVT-IBD vaccination of day-old specific pathogen-free chickens. The VP2 protein expressed by rHVT-IBD-infected chicken embryo fibroblasts was detected using the enzyme-linked immunosorbent assay and immunofluorescence. Using molecular techniques, the VP2 gene was detected in various organs, providing a method to monitor vaccine uptake. rHVT-IBD vaccination induced CMI responses in specific pathogen-free chickens at 5 weeks. CMI was detected by measuring chicken interferon-gamma after ex vivo antigenic stimulation of splenocytes. Moreover, our results showed that the enzyme-linked immunospot approach is more sensitive in detecting chicken interferon-gamma than enzyme-linked immunosorbent assay. The tools developed in this study may be useful in the characterization of new-generation recombinant vaccines and the cellular immune response they induce.
Collapse
Affiliation(s)
- Fiona Ingrao
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Fabienne Rauw
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Thierry van den Berg
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Bénédicte Lambrecht
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| |
Collapse
|
12
|
Rauw F, Van Borm S, Welby S, Ngabirano E, Gardin Y, Palya V, Lambrecht B. Quantification of rHVT-F genome load in feather follicles by specific real-time qPCR as an indicator of NDV-specific humoral immunity induced by day-old vaccination in SPF chickens. Avian Pathol 2015; 44:154-61. [PMID: 25687165 DOI: 10.1080/03079457.2015.1018869] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
The purpose of this study was to look for a reliable molecular method for confirmation of uptake of recombinant turkey herpesvirus vaccine against Newcastle disease (rHVT-F) and for use as a valuable prediction tool of Newcastle disease virus (NDV)-specific immune response in chickens deprived of maternally derived antibody (MDA). A quantitative real-time polymerase chain reaction (real-time qPCR) specific to rHVT-F was developed. The method was applied to various tissue samples taken from specific pathogen free (SPF) chickens experimentally inoculated at day-old with one dose of rHVT-F vaccine over a 6-week period. Among the tested tissues, the rHVT-F vaccine was detected predominantly in the bursa of Fabricius (BF) and the lung for the first week, followed by a progressive decline from 9 days onwards. Then, an increase of genome load was observed in the feather follicles (FF) with a peak at 2 weeks, rising to a level almost 10(3)-fold greater than in the other tissues. Importantly, the rHVT-F genome load in FF appeared to be strongly correlated to the humoral immunity specific to NDV as evaluated by haemagglutination inhibition (HI) test and NDV-specific IgG, IgM and IgA ELISAs. This is the first report of quantification of rHVT-F vaccine in FF and its correlation with the induction of ND-specific immune response in chickens with no MDA. Our data indicate that the application of this real-time qPCR assay on FF samples taken from chickens in the field may be used to confirm rHVT-F vaccine administration and uptake with the important added benefit of offering a non-disruptive sampling procedure.
Collapse
Affiliation(s)
- F Rauw
- a Veterinary and Agrochemical Research Centre (VAR) , Ukkel , Belgium
| | | | | | | | | | | | | |
Collapse
|
13
|
Ferreira HL, Rauw F, Pirlot JF, Reynard F, van den Berg T, Bublot M, Lambrecht B. Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge. Avian Pathol 2014; 43:68-77. [PMID: 24320551 DOI: 10.1080/03079457.2013.873111] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Avian influenza (AI) vaccines should be used as part of a whole comprehensive AI control programme. Vectored vaccines based on Newcastle disease virus (NDV) are very promising, but are so far licensed in only a few countries. In the present study, the immunogenicity and protection against a highly pathogenic H5N1 influenza challenge were evaluated after vaccination with an enterotropic NDV vector expressing an H5 haemagglutinin (rNDV-H5) in 1-day-old specific pathogen free chickens inoculated once, twice or once followed by a heterologous boost with an inactivated H5N9 vaccine (iH5N9). The heterologous prime/boost rNDV-H5/iH5N9 combination afforded the best level of protection against the H5N1 challenge performed at 6 weeks of age. Two rNDV-H5 administrations conferred a good level of protection after challenge, although only a cellular H5-specific response could be detected. Interestingly, a single administration of rNDV-H5 gave the same level of protection as the double administration but without any detectable H5-specific immune response. In contrast to AI immunity, a high humoral, mucosal and cellular NDV-specific immunity could be detected up to 6 weeks post vaccination after using the three different vaccination schedules. NDV-specific mucosal and cellular immune responses were slightly higher after double rNDV-H5 vaccination when compared with single inoculation. Finally, the heterologous prime/boost rNDV-H5/iH5N9 combination induced a broader detectable immunity including systemic, mucosal and cellular AI and NDV-specific responses.
Collapse
Affiliation(s)
- Helena Lage Ferreira
- a FZEA-USP , Av. Duque de Caxias Norte, 225, Pirassununga - SP, CEP 13635-900 , Brazil
| | | | | | | | | | | | | |
Collapse
|
14
|
Rauw F, Gardin Y, Palya V, van den Berg T, Lambrecht B. The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine. Avian Pathol 2013; 43:26-36. [DOI: 10.1080/03079457.2013.859655] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Dridi M, Rauw F, Muylkens B, Lecollinet S, van den Berg T, Lambrecht B. Setting up a SPF Chicken Model for the Pathotyping of West Nile Virus (WNV) Strains. Transbound Emerg Dis 2013; 60 Suppl 2:51-62. [DOI: 10.1111/tbed.12144] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2012] [Indexed: 11/30/2022]
Affiliation(s)
- M. Dridi
- Operational Direction of Viral Diseases; CODA-CERVA - Veterinary and Agrochemical Research Center; Brussels Belgium
| | - F. Rauw
- Operational Direction of Viral Diseases; CODA-CERVA - Veterinary and Agrochemical Research Center; Brussels Belgium
| | - B. Muylkens
- Integrated Veterinary Research Unit; University of Namur; Namur Belgium
| | - S. Lecollinet
- UMR1161 Virologie Institut National de la recherche Agronomique (INRA), agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Ecole Nationale Vétérinaire d'Alfort (ENVA); French Agency for Food, Environmental and Occupational Health & Safety - Anses; Maisons-Alfort France
| | - T. van den Berg
- Operational Direction of Viral Diseases; CODA-CERVA - Veterinary and Agrochemical Research Center; Brussels Belgium
| | - B. Lambrecht
- Operational Direction of Viral Diseases; CODA-CERVA - Veterinary and Agrochemical Research Center; Brussels Belgium
| |
Collapse
|
16
|
Ingrao F, Rauw F, Lambrecht B, van den Berg T. Infectious Bursal Disease: a complex host-pathogen interaction. Dev Comp Immunol 2013; 41:429-38. [PMID: 23567344 DOI: 10.1016/j.dci.2013.03.017] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2013] [Revised: 03/21/2013] [Accepted: 03/22/2013] [Indexed: 05/06/2023]
Abstract
Infectious Bursal Disease (IBD) is caused by a small, non-enveloped virus, highly resistant in the outside environment. Infectious Bursal Disease Virus (IBDV) targets the chicken's immune system in a very comprehensive and complex manner by destroying B lymphocytes, attracting T cells and activating macrophages. As an RNA virus, IBDV has a high mutation rate and may thus give rise to viruses with a modified antigenicity or increased virulence, as emphasized during the last decades. The molecular basis of pathogenicity and the exact cause of clinical disease and death are still poorly understood, as it is not clearly related to the severity of the lesions and the extent of the bursal damage. Recent works however, pointed out the role of an exacerbated innate immune response during the early stage of the infection with upregulated production of promediators that will induce a cytokine storm. In the case of IBDV, immunosuppression is both a direct consequence of the infection of specific target immune cells and an indirect consequence of the interactions occurring in the immune network of the host. Recovery from disease or subclinical infection will be followed by immunosuppression with more serious consequences if the strain is very virulent and infection occurs early in life. Although the immunosuppression caused by IBDV is principally directed towards B-lymphocytes, an effect on cell-mediated immunity (CMI) has also been demonstrated therefore increasing the impact of IBDV on the immunocompetence of the chicken. In addition to its zootechnical impact and its role in the development of secondary infections, it may affect the immune response of the chicken to subsequent vaccinations, essential in all types of intensive farming. Recent progress in the field of avian immunology has allowed a better knowledge of the immunological mechanisms involved in the disease but also should give improved tools for the measurement of immunosuppression in the field situation. Although satisfactory protection may be provided by the induction of high neutralizing antibody titres, interference from parental antibodies with vaccination has become the most important obstacle in the establishment of control programs. In this context, recombinant HVT and immune complex vaccines show promising results.
Collapse
Affiliation(s)
- Fiona Ingrao
- Avian Virology & Immunology Unit, Veterinary and Agrochemical Research Centre, Brussels, Belgium
| | | | | | | |
Collapse
|
17
|
Rauw F, Palya V, Gardin Y, Tatar-Kis T, Dorsey KM, Lambrecht B, van den Berg T. Efficacy of rHVT-AI Vector Vaccine in Broilers with Passive Immunity Against Challenge with Two Antigenically Divergent Egyptian Clade 2.2.1 HPAI H5N1 Strains. Avian Dis 2012; 56:913-22. [DOI: 10.1637/10172-041012-reg.1] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
18
|
Rauw F, Palya V, Van Borm S, Welby S, Tatar-Kis T, Gardin Y, Dorsey KM, Aly M, Hassan M, Soliman M, Lambrecht B, van den Berg T. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 2011; 29:2590-600. [DOI: 10.1016/j.vaccine.2011.01.048] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2010] [Revised: 12/07/2010] [Accepted: 01/18/2011] [Indexed: 10/18/2022]
|
19
|
Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S, van den Berg T, Lambrecht B. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol 2010; 134:249-58. [DOI: 10.1016/j.vetimm.2009.10.028] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2009] [Revised: 10/23/2009] [Accepted: 10/23/2009] [Indexed: 01/17/2023]
|
20
|
Rauw F, Gardin Y, Palya V, Anbari S, Lemaire S, Boschmans M, van den Berg T, Lambrecht B. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 2010; 28:823-33. [DOI: 10.1016/j.vaccine.2009.10.049] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2009] [Revised: 10/01/2009] [Accepted: 10/12/2009] [Indexed: 10/20/2022]
|
21
|
Rauw F, Gardin Y, Palya V, van Borm S, Gonze M, Lemaire S, van den Berg T, Lambrecht B. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine 2009; 27:3631-42. [DOI: 10.1016/j.vaccine.2009.03.068] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2008] [Revised: 03/11/2009] [Accepted: 03/17/2009] [Indexed: 10/20/2022]
|
22
|
Abstract
This study investigates the pivotal role of chicken interferon-gamma (ChIFNgamma) in the pathogenesis and immunosuppression of infectious bursal disease virus (IBDV) infection and is divided into in vivo, ex vivo and in vitro experiments. Two-week-old specific pathogen free chickens were inoculated with the 849VB very virulent strain of IBDV. The levels of systemic ChIFNgamma and chicken interleukin-6 in the serum were followed for 2 weeks during in vivo experiments. Then, splenocytes and bursal cells from infected chickens were analysed for their immunocompetence after mitogenic activation in ex vivo experiments. Finally, in vitro experiments were conducted to assess the direct immunosuppressive effect of ChIFNgamma on splenocytes and peripheral blood lymphocytes from non-inoculated specific pathogen free chickens. Our results reveal that the acute phase of infectious bursal disease coincides, on one hand, with high levels of systemic ChIFNgamma and chicken interleukin-6 and, on the other hand, with a strong inhibition of proliferation and activation of mitogen-stimulated splenocytes from infected chickens, as measured by ChIFNgamma production. Two weeks after viral inoculation, T lymphocytes infiltrating the bursa of Fabricius had recovered their activation capability. Finally, an in vitro study showed that the proliferation of naïve splenocytes and peripheral blood lymphocytes was directly and specifically inhibited by ChIFNgamma. In conclusion, a ChIFNgamma dysregulation occurs in chickens infected with IBDV and the overproduction of ChIFNgamma by T lymphocytes plays a key role in the pathogenesis and immunosuppression induced by this virus.
Collapse
Affiliation(s)
- Fabienne Rauw
- Avian Virology and Immunology Unit, Veterinary and Agrochemical Research Centre, Ukkel (Brussels), Belgium.
| | | | | |
Collapse
|
23
|
Rauw F, Lambrecht B, François A, Langlois P, van den Berg T. Kinetic And Biologic Properties of Recombinant ChIFN-γExpressed via CELO-Virus Vector. J Interferon Cytokine Res 2007; 27:111-8. [PMID: 17316138 DOI: 10.1089/jir.2006.0097] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
In this study, a replicative fowl adenovirus serotype 1 (CELO) recombinant expressing chicken interferon-gamma (ChIFN-gamma) was constructed. In the engineered recombinant, the ChIFN-gamma gene was placed under the control of cytomegalovirus (CMV) promoter. The ChIFN-gamma expression cassette was inserted in the right end of the CELO genome (D fragment), which was able to carry the largest insertion of foreign DNA without affecting the replication functions of the vector. The recombinant ChIFN-gamma (rChIFN-gamma) produced in the CELO-virus expression system was characterized by comparing its biologic activities with that of rChIFN-gamma produced via the baculovirus expression system (Bac-ChIFN-gamma). CELO-ChIFN-gamma inhibited the replication of cytolytic virus in chicken embryo fibroblasts (CEFs) and activated macrophages in a better manner than did Bac-ChIFN-gamma . Moreover, the in vitro and in vivo stability of the CELO-derived rChIFN-gamma was considerably higher than that of the Bac-ChIFN-gamma. The CELO-ChIFN-gamma recombinant vector was able to replicate in vitro in the loghorn male hepatoma (LMH) hepatocyte cell line and to produce detectable levels of recombinant cytokine in supernatant as early as 90 min post-infection. Therefore, the CELO-virus expression system is an appropriate system for high-level expression of biologically active and stable ChIFN-gamma.
Collapse
Affiliation(s)
- Fabienne Rauw
- Avian Virology and Immunology Unit, Veterinary and Agrochemical Research Centre (VAR), 1180 Ukkel, Brussels, Belgium.
| | | | | | | | | |
Collapse
|